On January 13th, 2023, a delegation led by Professor Qu Jia, Chairman of the Chinese Eye Valley Council, Director of the International Innovation Center, and General Hospital Director of the Wenzhou Medical University Eye Hospital Group; Professor Lv Fan, Director of the National Clinical Medical Research Center and Chief Scientist of the Chinese Eye Valley; and Dr. Xu Liangde, Secretary-General of the Chinese Eye Valley Council and Executive Director of the International Innovation Center, visited Big Vision Medical to conduct inspections and provide guidance work.
Chen Xinjian, Chairman of Big Vision Medical, introduced the company’s technological innovations and enterprise development in the field of ophthalmic AI hardware and software products. Professor Qu Jia and Professor Lv Fan fully recognized Big Vision Medical’s technological progress, clinical application achievements of products, and active participation in ophthalmic public welfare undertakings. They earnestly hoped that Big Vision Medical could make further progress and engage in comprehensive and in-depth cooperation with the Chinese Eye Valley to promote the innovative development of China’s ophthalmology industry.
As an eye health new R&D institution and industrial platform jointly established by the Longwan District Government and Wenzhou Medical University Affiliated Eye Hospital, the Chinese Eye Valley is currently the only comprehensive innovation complex for the ophthalmology industry in the country.
With the support of the medical, scientific research, educational, talent and transformation advantages of Wenzhou Medical University Affiliated Eye Hospital and four national-level science and technology innovation platform resources, the Chinese Eye Valley has established a leading industry-academia-research transformation system in China, promoting the development of the entire eye health industry chain to create a world-class technology R&D, industrial incubation, innovative talents, academic exchange, and high-end medical gathering zone.
As a high-tech enterprise focused on the research and development of ophthalmic image AI software and hardware systems, Big Vision Medical has established extensive and in-depth cooperation with Wenzhou Medical University Affiliated Eye Hospital.
Big Vision Medical’s fully automatic artificial intelligence OCT BV1000 has been successfully applied in the First People’s Hospital of Aksu District, which is supported by Wenzhou Medical University Affiliated Eye Hospital and Wenzhou Medical University. The independently developed ophthalmic OCT image-assisted diagnosis software MIAS 3000 is undergoing clinical trials at Wenzhou Medical University Affiliated Eye Hospital and is expected to become the world’s first OCT AI-assisted diagnosis product to receive Class III certification. Meanwhile, Big Vision Medical actively participates in public welfare activities organized by Wenzhou Medical University. In July 2021, the company participated in the “Tagong Brightness” public welfare project organized by Wenzhou Medical University with its fully automatic artificial intelligence OCT, providing eye examinations for up to 281 people in a single day in the Tibetan area. Big Vision’s ophthalmic AI is being used in more and more grassroots medical institutions and remote areas, providing effective solutions for insufficient ophthalmic medical resources in China with the help of advanced AI technology.
Big Vision Medical looks forward to making positive contributions to the technological progress of the ophthalmic industry and the public eye health cause, by collaborating with the Chinese Eye Valley and leveraging the industry agglomeration advantages of the innovation highland.
No comments yet.